Single cell transcriptome profiling has emerged as a breakthrough technology for 38 the high-resolution understanding of complex cellular systems. Here we report a flexible, cost-39 effective and user-friendly droplet-based microfluidics system, called the Nadia Instrument, 40 that can allow 3' mRNA capture of ~50,000 single cells or individual nuclei in a single run. 41
4 composition when combined with the Nadia Innovate. We subsequently demonstrate highly 90 reproducible droplet size, low doublet capture rates and high mRNA capture efficiencies 91 relative to alternative technologies. Further, we leverage our high quality datasets to elucidate 92 active transcriptional regulatory networks at different phases of the cell cycle. This revealed 93 transcription factors such as DRAP1, ZKSCAN1 and CEBPZ, among others, that had little or 94 no previous association with distinct phases of the cell cycle. Taken together, the integrity and 95 adaptability of the Nadia platform makes it an attractive and versatile platform for future single 96 facilitates high integrity co-encapsulation of single cells in oil droplets together with barcoded 106 beads (Figure 1A-C) . Unlike other custom or commercial systems that depend on mechanical 107 injection, the Nadia employs three pressure-driven pumps to deliver smooth and readily 108 manipulated liquid flows of cell suspensions, barcoded beads and oil into the platform's 109 microfluidics cartridges (Figure 1B-C) . Successful co-encapsulation of single cells with 110 individual beads subsequently represents the start point for cDNA library preparation. Between 111 1-8 samples can be processed in parallel on the Nadia due to the flexible configuration of the 112 machines inserted cartridge (Supplementary figure 1) , whilst incorporated magnetic stir bars 113 and cooling elements ensure samples remain evenly in suspension and temperature 114 controlled throughout. A touch interface guides the user through all essential experimental 115 steps, whilst optional integration of the paired 'Innovate' device provides the user with total 116 flexibility to modify all parameters of each run (Figure 1A) . Accordingly, new protocols can 117 subsequently be rapidly developed, saved and shared for future application by both the user 118 and the wider research community. Further, no wetted parts and disposable cartridges reduce 119 risk of cross-experiment contamination. 120 121 As with related microfluidic setups, single cell suspensions and barcoded beads are loaded at 122 limiting dilutions to ensure minimal occurrence of more than one cell in the same droplet with 123 a bead (Figure 1C) . Following cell and bead co-encapsulation, the oil droplets act as 124 chambers for cell lysis and mRNA capture. Current injection-based microfluidics systems have 125 been restricted to single droplet sizes 16 , or require custom microfluidics chips designed for 126 5 purpose 9,14 . However, retaining the ability to fine-tune droplet volumes could concentrate RNA 127 around oligo bound capture beads for increased mRNA capture, and allow droplet parameters 128 to be optimised according to cell dimensions, buffers or the capture beads used. Exemplifying 129 this, whilst original reports used ~125 μm diameter droplets for transcriptome profiling whole 130 cells 9 , Habib et al. optimised a microfluidics chip for ~85 μm diameter droplet generation that 131 facilitated single-nuclei sequencing of archived human brain tissue 14 . Due to the smooth 132 pressure-based system employed, and unlike other platforms, droplet manipulation is readily 133 achieved with the Nadia and accompanying Innovate. Indeed, droplets can be generated over 134 a range of sizes from as little as ~40 μm (Figure 1D, E) . Moreover, this can be achieved using 135 the same microfluidics cartridge for all droplet sizes, thus negating the need for custom chip 136 design between experiments. Crucially, resulting droplets are uniform in size (Figure 1E, F) . 137
Meanwhile, reducing droplet size from ~85 μm to ~60 μm (p < 0.05, Figure 1F ) resulted in 138 increased RNA capture from mouse 3T3 nuclei ( Figure 1G) . 139
140
Beyond droplet size control, current droplet-sequencing protocols have principally reported 141 use of two oligonucleotide bound beads; non-deformable beads 9 , and deformable 142 hydrogels 16,18 . Non-deformable beads have the advantage that mRNA-bound beads can be 143 pooled prior to reverse transcription and minimise reagent costs. In contrast, deformable 144 beads, including those used in commercial platforms 16 , require the reverse transcription 145 reaction to be performed within the droplets to ensure cellular barcodes remain specific to a 146 single cell following oligo release from the hydrogel surface. A reverse transcription mix must 147 thus constitute one of the three streams entering the microfluidics setup which can increase 148 reagent usage. However, whilst droplet-sequencing with non-deformable beads is dependent 149 on double Poisson loading constraints that restricts bead encapsulation to <20%, deformable 150 hydrogels can be efficiently synchronized such that 70-100% of droplets contain a single 151 bead 16, 18 . Whilst the bead configuration is dependent on the application in question, the Nadia 152 importantly retains flexibility to use both non-deformable and deformable beads unlike other 153 platforms 19 . Indeed, whilst non-deformable beads have been used for datasets presented 154 herein, acrylamide/bis-acrylamide deformable beads are fully compatible and allow successful 155 bead stacking behind the microfluidics junction to facilitate synchronised loading of >70% of 156 droplets ( Figure 1H) . 157 158 Similar flexibility is provided in the ability to incorporate different buffers. Indeed, stable and 159 mono-dispersed oil droplets are created with a cell/nuclei lysis buffer containing 0.2% sarkosyl 160 and 6 % of the Ficoll PM-400 sucrose-polymer, and a cytoplasmic lysis buffer containing 0.5% 161 Igepal CA-630 (Supplementary figure 1) . Meanwhile, in an alternative application, use of 162 hyrdogel liquid precursors in replace of the bead-containing lysis buffer can allow hydrogel 163 6 based capture of the cell suspension to create miniaturized and biocompatible niches for three 164 dimensional in vitro cell culture (Supplementary figure 1) 20 . Taken together then, the Nadia 165 provides a flexible setup that allows the user to optimise experimental parameters for specific 166 purpose. 167
168
Technical performance for single cell and single nuclei sequencing: In order to test the 169 integrity of the Nadia platform, we performed a mixed-species experiment in which a 3:1 mix 170 of human HEK293 cells and mouse 3T3 cells were subject to droplet capture using the 171 standard machine parameters. During cDNA library preparation, 2000 beads were processed 172 into a final library for sequencing. This number would theoretically equate to profiling of 100 173 cells under double Poisson loading constraints, and just ~1.25% of the total cells collected in 174 this run. Following sequencing at >100k reads per cell, our analysis with the Drop-seq tools 175 pipeline 9 revealed we had collected precisely 100 single cell transcriptomes attached to 176 microparticles (STAMPs). Of these, 75 had mappings primarily to the human genome, and 24 177 to the mouse genome (Figure 2A) . Just 1% had mixed mappings that implied capture of more 178 than two mixed species cells during the microfluidics element of the workflow. Meanwhile, 179 each single species cell had a mean of 1.52% reads from the alternative species to imply a 180 low-level of barcode swapping during library preparation. A low doublet capture rate was 181 maintained when the number of beads used for cDNA library preparation was increased, whilst 182 increasing the loading density of cells revealed an increase in doublets consistent with the 183 double Poisson loading of the platform (Supplementary figure 2) . 184
185
We next produced cDNA libraries from different amounts of barcoded beads to determine 186 whether STAMP estimates matched the theoretical cell capture of the system. To assess we 187 evaluated the number of UMI counts associated with cell barcodes, and used subsequent 188 graph inflection points to estimate the cells captured. Across multiple experiments performed 189 by independent users at different locations, we saw that the predicted STAMP capture was 190 well matched to expected cell capture ( Figure 2B) . Further, by comparing UMI and gene 191 counts to the total read counts for each library, we found that using the Nadia platform resulted Applying such a strategy is necessary when profiling heterogeneous cell samples that cannot 199 be readily dissociated into single cell suspensions (e.g. due to long cellular projections), or 200 7 when profiling archived samples not robust to freeze-thaw conditions. As such, single-nuclei 201 sequencing is emerging as a method of choice for study of archived human brain tissue 3, 14, 21, 22 . 202
With such future applications in mind, we evaluated the ability of the Nadia platform to profile 203 single nuclei suspensions of mouse 3T3 cells and human HEK293 cells, or mouse 3T3 cells 204 alone. As with whole cell suspensions, mixed-species plots revealed a low doublet rate 205 (Supplementary figure 2) . In agreement with previous single nuclei sequencing studies 14,23 , 206 a higher level of intronic reads were reported relative to whole cells (Supplementary figure  207 3). Meanwhile, we found the Nadia platform had nuclear RNA capture rates that compared 208 favourably to limited publically available single nuclei RNA-seq data and approached whole-209 cell datasets (Figure 2E-F) 14 . Whilst capture was marginally reduced relative to whole-cell 210 profiling, the ability to fine-tune droplet dimensions with the Innovate has potential to improve 211 nuclear RNA capture in future (e.g. 14 ). Indeed, we observed an increase in cDNA generated 212 when droplets were reduced from ~85 μm to ~60 μm ( Figure 1H) . our "Nadia 12k" mixed-species experiment. Similar to a previous Drop-seq study 9 , and despite 222 the dataset being generated from two asynchronous cell populations, in both species we were 223 able to use gene expression profiles to infer five phases of the cell cycle that matched previous 224 stages of chemically synchronized cells ( Figure 3A ) 24 . This phase assignment was supported 225 by the cycling expression of certain established and novel cell cycle-associated genes, but not 226 housekeeper genes (Supplementary figure 4) . 227
228 Analysis of single cell gene expression profiles at different stages has previously been used 229 to identify novel genes correlated to cell cycle phases 9 , but the identity of the master regulators 230 that drive coordinated cell-cycle gene-expression programmes remains incompletely 231 understood. Accordingly, we took an alternative approach and questioned whether 232 summarised expression of transcription factor target networks, herein referred to as regulons, 233 could be leveraged to infer the transcriptional regulators active in specific cell cycle phases. 234
Indeed, low depths of sequencing and the absence of mRNA capture for many genes in 235 individual cells (dropouts) can make single cell datasets ineffective in precisely quantitating 236 the expression of individual genes. Meanwhile, many transcription factors can be regulated 237 8 post-transcriptionally such that their mRNA abundance is not a reliable proxy for protein 238 activity. In contrast, regulon enrichments evaluate differential expression of many 239 transcriptional targets such that these biological and measurement sources of noise are 240 effectively averaged out. 241
242
To apply this strategy to the cell cycle we first turned to the manually curated TRRUST 243 database of human and mouse regulons that have been determined from sentence-based text 244 mining 25 . After filtering 800 human and 828 mouse regulons to those expressed in our datasets 245 together with >10 targets, summarised expression profiles were generated for regulons of 77 This included RFXANK, DRAP1 and HES4 which were correlated with G1/S phase, ZNF33A, 292 VEZF1, ZKSCAN1 which correlated with G2/M phase, and ZNF146, CEBPZ and KLF3 that 293 were maximally correlated with mitosis ( Supplementary Table) . Unlike the others, RFXANK, 294 DRAP1, ZKSCAN1, CEBPZ and KLF3 had no clear relationship between cycling expression 295 levels and activity (Figure 3E, Supplementary Figure 5 ). Accordingly, it will now be important 296 to determine how the phased-activity of these novel cell cycle associated transcription factors 297 manifests in the absence of regulation at the level of gene expression. Indeed, the recent 298 findings that levels of ZKSCAN1 modulate hepatocellular carcinoma progression in vivo and 299 in vitro 42 , HES4 expression is linked to osteosarcoma prognosis 43 , and that KLF3 loss temperatures, buffer types and bead composition. The scalability that is achievable through 327 the multiplexed and parallel processing of up to 8 samples can further match or exceed that 328 of other comparable platforms 10,16 . We demonstrate a high integrity and quality of the 329 transcriptome profiles generated when using the Nadia. Indeed, with standard settings we 330 report a low doublet rate between 1-7% (Fig 2A, Supplementary Figure 2) , and favorable RNA 331 capture efficiencies for both single cell and single nuclei sequencing compared to other reports 332 and commercial platforms 9,14,16 . Last, the ease-of-use and speed of microfluidics capture will 333 ensure experiment start-to-finish times are kept to a minimum. Accordingly, unintended 334 sample lysis and RNA degradation due to extended protocols is mitigated. 335
336
We used the Nadia platform and droplet sequencing workflow to profile the transcriptomes of 337 asynchronous human and mouse cells that subsequently allowed us to infer the different 338 phases of the cell cycle. Notably, the high complexity cDNA libraries allowed us to characterise 339 the cells by transcription factor activity using recently developed systems biology approaches. 340
Our analysis uncovered 83 human transcription factors with inferred activity correlated with 341 one or more cell cycle phase. Despite this, and as noted previously 37 , the employed 342 metaVIPER approach cannot accurately measure activity of proteins whose regulons are not 343
represented adequately in one of the interactomes used for regulon inference. Accordingly, 344 this may explain the absence of overlap between TRRUST curated regulons and those derived 345 from 24 TCGA human cancer tissue sets. However, the expected phase-specific activity of paucity of knowledge about each of these factors ( Supplementary Table) . It will now be 358 important to experimentally dissect the roles and importance of these novel factors to 359 proliferating cells, how their activity is precisely controlled across phases, and determine their 360 roles in disease. Indeed, the aforementioned links between ZKSCAN1 levels and 361 hepatocellular carcinoma 42 , HES4 levels and osteosarcoma 43 , and KLF3 levels with colorectal 362 cancer 44 suggests enhanced understanding of these factors in the context of the cell cycle 363 could have translational potential. 364
365
In summary then, and as evidenced by our analysis of the cell cycle, the Nadia platforms's 366 high quality output coupled with its' flexibility across different buffers, workflows and user-367 determined parameters suggest it will be an attractive technology for future transcriptomic 368 studies at cell resolution. NextSeq 500 sequencer at the Imperial BRC genomics facility. Samples were run using a 489 custom read 1 primer (Read1customSeq). Read 1 was set at >20 base pairs to read through 490 the cellular and molecular barcodes, and read 2 set at >25 base pairs to read cDNA inserts. factor targets were downloaded from the TRRUST v2 database 25 . Regulons were 529 subsequently filtered to those expressed in respective human and mouse cell datasets 530 alongside >10 identified targets. Transcription factor activity was subsequently scored in 531 individual cells by averaging the normalised expression levels of the genes in each regulon. 532
The mean scores for each regulon were mean centred and standard deviation normalised 533 across all cells. Normalised inferred regulon activity of individual cells was subsequently 534 correlated with the previously inferred phase-specific scores, with those having a significant 535 (p < 0.01) pearson correlation of >0.3 with one or more phases being used for presentation. 536
The cor.test function of the stats (v. 3.6.1) R package was used for calculation of pearson 537 correlation and test statistics. For figures 3D and 3E, regulons used were previously derived 538 from 24 TCGA human cancer RNA-seq datasets and accessed from the 'aracne.networks' R 539 package. VIPER (v.1.18.1) 36,37 was used to score all regulons from the 24 TCGA human 540 cancers in all individual human HEK293 cells, before the average of all normalised enrichment 541 scores (i.e. avgScore) for each specific master regulator was used to integrate scores into a 542 single metric. The mean scores for each regulon were mean centred and standard deviation 543 normalised across all cells. Inferred regulon activity of individual cells was subsequently 544 correlated with the previously inferred phase-specific scores, with those having a pearson 545 correlation of >0.35 with one or more phases being used for presentation. 546 547 Data availability: Study generated transcriptomic data has been deposited in the GEO 548 repository and will be made available upon publication. External datasets were collected from 549 
